1. College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China; 2. Department of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng 224005, China; 3. Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang 222047, China
Abstract��Ginkgo biloba is a kind of ancient relict woody. It is a common homologous plant of medicine and food. Its leaves and fruits can produce secondary metabolites, such as flavonoids and ginkgolide, which have good medicinal effects. Ginkgo biloba leaves have low toxicity and broad-spectrum pharmacological activity. The research showed that ginkgo flavonoid has the effect of anticancer and cancer prevention. It is a potential chemical for cancer prophylaxis, which can significantly reduce the incidence of many malignant cancers. The progress in research on the structures, antitumor effects, and mechanism of flavonoids of Ginkgo biloba is summarized in this article, which provides a pharmacological basis for the deep processing and comprehensive utilization of Ginkgo biloba.
KE Y P, KAO W C, TSANG L K, et al. Research progress on prevention and cure forhormone dependent neoplasm by phytoestrogens. World J Cancer Res, 2013, 3:13-16.
[2]
MA J X, LI H Q. Phytoestrogens and cancer. Foreign Med Sci(����ҽѧ), 2001, 18(6):416-419.
[3]
HASLER A, GROSS G A, MEIER B, et al. Complex flavonol glycosides from the leaves of Ginkgo biloba. Phytochemistry, 1992, 31(4):1391-1394.
[4]
HU R R, YAO X, et al. Determination of ten flavonoids in ginkgo leaves extract from different manufacturers by UPLC-MS/MS. Chin J Exp Tradit Med Form(�й�ʵ�鷽��ѧ��־), 2017,23(24):90-95.
[5]
[5] TANG Y P, LOU F C, WANG J H, et al. Studies on the constituentes of flavonoids from Ginkgo biloba leaves. Chin Pharm J(�й�ҩѧ��־), 2001, 36(4):231-233.
[6]
HASLER A, STICHER O, MEIER B. Identification and determination of the flavonoids from Ginkgo biloba by high-performance liquid chromatography. J Chromatogr A, 1992, 605(1):41-46.
[7]
TANG Y P, WAND Y, LOU F C, et al. Flavonol glycosides from the leaves of Ginkgo biloba.Acta Pharm Sin(ҩѧѧ��), 2000, 35(5):363-366.
[8]
VICTOIRE C, HAAG B M, LOBSTEING A, et al. Isolation of flavonol glycosides from Ginkgo biloba leaves. Planta Med, 1988, 54(3):245-247.
[9]
VANHAELEN M, VANHAELENFASTRE R. Flavonol triglycosides from Ginkgo biloba. Planta Med, 1989, 55(2):202-202.
[10]
LOBSTEIN G A, BRIANCON S F, VICTOIRE C, et al. Isolation of amentoflavone from Ginkgo biloba. Planta Med, 1988, 54(3):245-247.
[11]
BEDIR E, TATLI I, KHAN R, et al. Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem, 2002, 50(11):3150-3155.
[12]
VANB T, MONTORO P. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J Chromatogr A, 2009, 1216(11):2002-2032.
[13]
LI B, HU G S, HU L L, et al. Isolation and determination of biflavonoids in Ginkgo biloba leaves. Chin Tradit Herb Drugs(�в�ҩ), 2014,(17):2552-2555.
[14]
JOLY M, HAAGBERRURIER M, ANTON R. 5��-Methoxybilobetine, une biflavone extraite du Ginkgo biloba. Phytochenistry, 1980, 19(9):1999-2002.
[15]
YOU S, YAO X S, CHEN Y. Advances in chemistry and pharmacology of Ginkgo biloba. J Shenyang Coll Pharm(����ҩѧԺѧ��), 1988,5(2):142-145.
[16]
KRAUZE B M, SOWIA S PY. 2, 3-Dihydrobiflavone from Ginkgo biloba. Planta Med, 1999, 65(5):482-484.
[17]
CHI J D, XU L X Y. Studies on a flavonoid compound in Ginkgo biloba L. Leaves. China J Chin Mater Med(�й���ҩ��־), 1998, 23(4):233-234.
[18]
DERKSEN G, NIEDERLANDER H, VAN B Y. Analysis of anthraquinones in Rubia tinctorum L. by liquid chromatography coupled with diodearray UV and mass spectrometric detection. J Chromatogr A, 2002, 978(1):119-127.
[19]
KRAUZE M, WIWART M. Antifungal activity of biflavones from Taxus baccata and Ginkgo biloba. Z Fur Naturforschung C A J Biosciences, 2003, 58(2):65-69.
[20]
KRAUZE B M, BACZEK T, GLOD D, et al. HPLC Separation of O-acylated flavonoids and biflavones from some species of gymnospermae. Chromatogarphia, 2004, 60(1-2):9-15.
[21]
STAFFORD H, KREITLOW K, LESTER H.Comparison of proanthocyanidins and related compounds in leaves and leaf-derived cell cultures of Ginkgo bioloba L, Pseudotsuga menziesii Franco, and Ribes sanguineum Pursh.. Plant Physiol, 1986, 82(4):1132-1138.
[22]
NATELLA F, NARDINI M, VIRGILI F, et al. Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets, 2007, 18(3):224-243.
[23]
QA��DAN F.Prodelphinidins from Gingko biloba leaves. Planta Med, 2008, 74(9):1062.
[24]
XIE H, WANG J, YAU L, et al. Catechins and procyanidins of Ginkgo biloba show potent activities towards the inhibition of �P2-amyloid peptide aggregation and destabilization of preformed fibrils.Molecules, 2014, 19(4):5119.
[25]
STAFFORD H A, LESTER H H. Proanthocyanidins and potential precursors in needles of douglas fir and in cell suspension cultures derived from seedling shoot tissues. Plant Physiol, 1981, 68(5):1035-1042.
[26]
WOERDENBAG H, BEEK T. Adverse Effects of Herbal Drugs. Ginkgo biloba. Vol 3.Berlin Heidelberg:Springer, 1997:51-66.
[27]
BEECHER G. Proanthocyanidins:biological activities associated with human health.Pharm Biol, 2004, 42(s1):2-20.
[28]
The latest national cancer report in 2018:7 people are diagnosed with cancer every minute. Xinmin Weekly(�����ܿ�), 2018(14):53-53.
[29]
ZHAN H Q, DONG T X, LOU J X.New application of Ginkgo biloba flavonoids:China CN201610579579.0. 2016-11-30.
[30]
JIANG Z Q, LI M H, QIN Y M, et al. Luteolin inhibits tumorigenesis and induces apoptosis of non-small cell lung cancer cells via regulation of MicroRNA-34a-5p. Int J Mol Sci, 2018, 19(2):1-18.
[31]
LI Q, REN F, YANG C, et al. Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo. Asian Pac J Cancer Prevention, 2015, 16(7):3035-3042.
[32]
ZHU L, WANG Z R, ZHOU L M, et al. Effects and mechanisms of isorhamnetin on lung carcinoma. Space Med Med Eng(����ҽѧ��ҽѧ����), 2005, 18(5):381-383.
[33]
ZHU Y, SUN L, ZHANG H, et al. Effects of isorhamnetin on protein expression of VEGF, MMP-2 and endostatin in lewis lung cancer mouse. Int J Clin Exp Med, 2017, 10(8):11488-11495.
[34]
ABD E, SHEHAB G, NASHAAT H. Epigallocatechin-3-gallate: the prospective targeting of cancer stem cells and preventing metastasis of chemically-induced mammary cancer in rats. Am J Med Sci, 2017, 354(1):54-63.
[35]
HONG J, FRISTIOHADY A, NGUYEN C, et al. Apigenin and luteolin attenuate the breaching of MDA-MB231 breast cancer spheroids through the lymph endothelial barrier in vitro. Frontpharmacol, 2018, 9(220):1-10.
[36]
ZHANG F, YANG G W, ZHANG J F, et al. Inhibltory effects of Ginkgo biloba leaf flavonoids on proliferation of human gastric cancer cell line BGC823 in vitro. World Chin J Digestol(���绪��������־), 2005, 13(21):2627-2630.
[37]
QIAN Y, XIA L, SHI W, et al. The effect of EGB on proliferation of gastric carcinoma SGC7901 cells. Clin Transl Oncol, 2015, 18(5):521-526.
[38]
DU N. Inhibitory effect of quercetin flavone and Ginkgo biloba injection on tumor-bearing mice. Hebei:Hebei University, 2015.
[39]
KIM B, JEON Y, NAM M. A mechanism of apigenin-induced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells.Food Chemtoxicol, 2011, 49(7):1626-1632.
[40]
YE B, EDWARDS D, BERKOWITZ R, et al. Epidemiological and biological evidence for protective effect of Ginkgo biloba on ovarian cancer.Cancer Res, 2005, 9(46):1-10.
[41]
SUN F. Study on compatibility optimization of flavone monomer combination drugs based on star design. Shandong:Shandong University of Traditional Chinese Medicine, 2014.
[42]
LIU Q, ZHU D, HAO B, et al. Luteolin promotes the sensitivity of cisplatin in ovarian cancer by decreasing PRPA1-medicated autophagy. Cell Mol Biol(Noisylegrand), 2018, 64(6):17-22.
[43]
CHEN L, YAN F, CHEN W, et al. Procyanidin from peanut skin induces antiproliferative effect in human prostate carcinoma cells DU145. Chem Biol Interact, 2018, 288(25):12-23.
[44]
MAMOUNI K, ZHANG S, LI X, et al. A novel flavonoid composition targets androgen receptor signaling and inhibits prostate cancer growth in preclinical models. Neoplasia, 2018, 20(8):789-799.
[45]
ZHANG L, WANG S, LIU Z, et al. Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge. Inter Intimmunopharmacol, 2017, 47:251-258.
[46]
XU F Y, GAO M M, MUHEBULI A. Advances in anti-tumor mechanisms of natural flavonoids. J Xinjiang Med Univ(�½�ҽ�ƴ�ѧѧ��), 2013,(2):171-176.
[47]
LONG C. Extraction, Antioxidant Activity and Structure-Activity Relationship of Ginkgo Flavonoids. Chongqing:Chongqing University, 2006.
[48]
SAO J F, JIN H T, ZHU H W, et al. Optimization of parameters for ethanol extraction of flavone glycosides from ginkgo cell and antioxidant activity in vitro. J China Univ Mining Technol(�й���ҵ��ѧѧ��), 2013, 42(4):663-669.
[49]
ZENG X Y, ZENG X B. Study on the activity of antitumor and antioxidants of total flavonoids in Ginkgo biloba leaves. J Clin Res(ҽѧ�ٴ��о�), 2016,33(3):528-531.
[50]
ERLEJMAN A, FRAGA C, OTEIZA P.Procyanidins protect Caco-2 cells from bileacid-and oxidant-induced damage. Free Radic Biol Med, 2006, 41(8):1247-1256.
[51]
SUN S, GONG F, LIU P, et al. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. Gene, 2018, 664:50-57.
[52]
CHEN K, CHEN Q, HUANG C R, et al. Advances in anti-tumor mechanisms of total flavonoids from plants. J Jilin Med College(����ҽҩѧԺѧ��), 2015,41(4):293-296.
[53]
FANG J, ZHOU Q, LIU L Z, et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression.Carcinogenesis, 2007, 28(4):858-864.
[54]
LI X, FENG Y, LIU J, et al. Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1alpha and VEGF expression. J Nutrigenet Nutrigenomics, 2013, 6(3):169-178.
[55]
YEE E, BRANDL M, PASQUIER E, et al. Dextran-catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells. Sci Rep, 2017, 7(1):7638-7647.
[56]
LI Y S, WU L P, LI K H, et al. Involvement of nuclear factor kappaB (NF-kappaB) in the downregulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells. J Int Med Res, 2011, 39(6):2141-2150.
[57]
MSS M, ARAG O S, CARMO D, et al. Curcumin and Rutin Down-regulate Cyclooxygenase-2 and Reduce Tumor-associated Inflammation in HPV16-Transgenic Mice. Anticancer Res, 2018, 38(3): 1461-1469.
[58]
ZHANG L, LI D, CAO F, et al. Identification of human acetylcholine esterase inhibitors from the constituents of EGb761 by modeling docking and molecular dynamics simulations. Comb Chem High Throughput Screen, 2018, 21(1):41-49.
[59]
ZHANG L H, LI D D, XIAO W, et al. Prediction of anti-inflammatory mechanism of Ginkgo biloba extract based on network pharmacology and molecular docking. Chin J Exp Tradit Med Form(�й�ʵ�鷽��ѧ��־), 2018, 24(7):192-198.
[60]
RU J, LI P, WANG J, et al. TCMSP:a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform, 2014, 6:13-18.
2019, Vol. 54 
